These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 16830652

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A, Girdhar A, Girdhar BK.
    Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
    [Abstract] [Full Text] [Related]

  • 24. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME, Alvim MF, Nery JA, Albuquerque EC, Sarno EN.
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [Abstract] [Full Text] [Related]

  • 25. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [Abstract] [Full Text] [Related]

  • 26. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP, Malta AM, Sarno EN, Kaplan G.
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [Abstract] [Full Text] [Related]

  • 27. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Bhatia AS, Sreevatsa, Gupta UD, Sharma VD, Shivannavar CT, Patil MA, Bharadwaj VP.
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP, Khambati FA, Ghate SD, Capadia GD, Pai VV, Ganapati R.
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serological monitoring of the response to chemotherapy in leprosy patients.
    Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
    [Abstract] [Full Text] [Related]

  • 34. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
    Becx-Bleumink M.
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
    [Abstract] [Full Text] [Related]

  • 35. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR, Pai VV, Samy MS, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
    Tejasvi T, Khaitan BK, Khanna N, Pandhi RK, Singh MK.
    Indian J Lepr; 2006 Sep; 78(4):329-37. PubMed ID: 17402345
    [Abstract] [Full Text] [Related]

  • 37. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P, Bundit C, Kuhacharoen N, Peerapakorn S, Kampirapap K, Poomlek A, Bampenyu S, Tiasiri S, Rungruang S, Surasondhi S, Supanwanit S, Wiriyawipart S.
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [Abstract] [Full Text] [Related]

  • 38. Intrabacterial sodium-to-potassium ratios and ATP contents of Mycobacterium leprae from ofloxacin-treated patients.
    Dietz M, Haas M, Lindner B, Dhople AM, Tebebe YB, Seydel U.
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):548-57. PubMed ID: 1802937
    [Abstract] [Full Text] [Related]

  • 39. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
    Gupta UD, Katoch K, Natarajan M, Sharma VD, Sharma RK, Shivannavar CT, Katoch VM.
    Acta Leprol; 1997 Dec; 10(4):209-12. PubMed ID: 9447254
    [Abstract] [Full Text] [Related]

  • 40. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
    Katoch VM, Katoch K, Ramanathan U, Sharma VD, Shivannavar CT, Datta AK, Bharadwaj VP.
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.